- 英文名称
- Ganaxolone
- 分子式
- C22H36O2
- 分子量
- 332.52
- 中文别名
- 加奈缩酮; (3Α,5Α)-3-羟基-3-甲基孕甾-20-酮; 1-((3R,5S,8R,9S,10S,13S,14S,17S)-3-羟基-3,10,13-三甲基十六氢-1H-环戊二烯并[a]菲-17-基)乙酮; 加那索龙; 加那索酮; 3α-hydroxy-3β-methyl-5α-pregnan-20-one; (3α,5α)-3-Hydroxy-3-methyl-pregnan-20-one; 1-((3R,5S,8R,9S,10S,13S,14S,17S)-3-Hydroxy-3,10,13-trimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)ethanone; (3α,5α)-3-Hydroxy-3-methylpregnan-20-one; 1-[(3R,5S,8R,9S,10S,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone; Pregnan-20-one, 3-hydroxy-3-methyl-, (3α,5α)-; 5α-PREGNAN-3β-METHYL-3α-OL-20-ONE; CCD-1042
- 用途
- 生命科学;加奈索酮通过正向调节GABAA受体发挥作用,GABAA受体是中枢神经系统主要抑制性神经递质受体,调节作用有助于减少与CDD相关癫痫发作的频率和严重程度,作为首创神经活性类固醇,用于治疗CDD相关癫痫发作。